ILYPSA Trademark

Trademark Overview

On Thursday, December 18, 2008, a trademark application was filed for ILYPSA with the United States Patent and Trademark Office. The USPTO has given the ILYPSA trademark a serial number of 77636146. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 20, 2012. This trademark is owned by Ilypsa, Inc.. The ILYPSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of renal, metabolic, cardiovascular and infectious diseases in humans
ilypsa

General Information

Serial Number77636146
Word MarkILYPSA
Filing DateThursday, December 18, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 20, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of renal, metabolic, cardiovascular and infectious diseases in humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 22, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIlypsa, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameIlypsa, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, August 20, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 20, 2012ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 29, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2011EXTENSION 5 GRANTED
Friday, December 16, 2011EXTENSION 5 FILED
Friday, December 16, 2011TEAS EXTENSION RECEIVED
Tuesday, June 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 20, 2011EXTENSION 4 GRANTED
Friday, June 17, 2011EXTENSION 4 FILED
Friday, June 17, 2011TEAS EXTENSION RECEIVED
Thursday, December 16, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 15, 2010EXTENSION 3 GRANTED
Monday, December 13, 2010EXTENSION 3 FILED
Monday, December 13, 2010TEAS EXTENSION RECEIVED
Wednesday, June 2, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 1, 2010EXTENSION 2 GRANTED
Friday, May 28, 2010EXTENSION 2 FILED
Friday, May 28, 2010TEAS EXTENSION RECEIVED
Monday, February 1, 2010EXTENSION 1 GRANTED
Monday, December 21, 2009EXTENSION 1 FILED
Monday, February 1, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 21, 2009TEAS EXTENSION RECEIVED
Friday, November 27, 2009ASSIGNED TO EXAMINER
Tuesday, July 21, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2009NOTICE OF PUBLICATION
Thursday, March 26, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 25, 2009ASSIGNED TO LIE
Wednesday, March 25, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 25, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, March 25, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 25, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, March 25, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, March 16, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 16, 2009NON-FINAL ACTION E-MAILED
Monday, March 16, 2009NON-FINAL ACTION WRITTEN
Friday, March 13, 2009ASSIGNED TO EXAMINER
Monday, December 22, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

ilypsa infectious diseases humans cardiovascular metabolic preparations treatment renal pharmaceutical